The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

30 Mar 2020 14:05

RNS Number : 0877I
Sensyne Health PLC
30 March 2020
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APMBXGDXUGXDGGG
Date   Source Headline
31st Jul 20197:00 amRNSCollaboration Agreement with Bayer
9th Jul 20197:00 amRNSHoldings in Company
1st Jul 20192:05 pmRNSSecond Price Monitoring Extn
1st Jul 20192:00 pmRNSPrice Monitoring Extension
27th Jun 20194:48 pmRNSHolding(s) in Company
27th Jun 20194:42 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSEY announcement on AI and blockchain
24th Jun 20197:00 amRNSLAB10x partnership for data-driven drug discovery
30th Apr 20197:00 amRNSBayer joins Sensyne Health consortium
28th Jan 20197:02 amRNSResearch alliance with Big Data Institute
28th Jan 20197:02 amRNSAgreement with Jefferson Health in US
28th Jan 20197:02 amRNSSigns SRA with Wye Valley NHS Trust
28th Jan 20197:02 amRNSSigns SRA with George Eliot Hospital NHS Trust
28th Jan 20197:02 amRNSSensyne Health Maiden Interim Results 2018
15th Jan 20197:00 amRNSNotice of Interim Results
5th Dec 201810:41 amRNSAnnouncement on National Health Data
21st Nov 20187:00 amRNSStrategic advisory services agreement with EY
24th Oct 20187:00 amRNSBoard Change
16th Oct 20187:00 amRNSOfficial product launch of GDm-HealthT
3rd Oct 20187:00 amRNSBoard Appointment
2nd Oct 20187:00 amRNSChange of Registered Office
28th Sep 201811:56 amRNSHolding(s) in Company
6th Sep 20181:19 pmRNSSensyne Health welcomes government code of conduct
21st Aug 20183:28 pmRNSHoldings in Company
20th Aug 20185:32 pmRNSHoldings in Company
20th Aug 20184:52 pmRNSHoldings in Company
17th Aug 20188:04 amRNSAdmission to AIM & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.